Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

January 19, 2022

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

Advances in Rheumatology
Anna Carolina Faria Moreira Gomes TavaresGecilmara Cristina Salviato Pileggi
January 19, 2022

Japanese Single-Center Experience of Kidney Transplant: Experience in a Japanese Private Hospital.

Transplantation Proceedings
Tomokazu ShimizuHiroshi Toma
January 19, 2022

Immune checkpoint inhibitor-induced diabetes mellitus with pembrolizumab.

BMJ Case Reports
Anis Zand IraniHolly Gibbons
January 19, 2022

Parotid gland metastasis of lung adenocarcinoma identified on surveillance 18F-FDG PET/CT.

BMJ Case Reports
Nicolas Adrianto SoputroJessica Prasad
January 19, 2022

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability.

Nature Nanotechnology
Jacqueline A BurkeEvan A Scott
January 19, 2022

Postvaccinal Encephalopathy Presenting with Amnesia and Seizure After ChAdOx1 nCov-19 Vaccination: A Case Report.

Acta Neurologica Taiwanica
Yuan-Ju Huang, Chih-Shan Huang
January 19, 2022

Epigenetic Platinum Complexes Breaking the "Eat Me/Don't Eat Me" Balance for Enhanced Cancer Chemoimmunotherapy.

Bioconjugate Chemistry
Longlong TianZhuang Liu
January 19, 2022

Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Mukaddes TozluAydin Seref Koksal
January 19, 2022

Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.

The Journal of Clinical Investigation
David F FiorentinoLivia Casciola-Rosen
January 18, 2022

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 Vaccine in kidney transplant recipients.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Giuseppe Stefano NettiGiovanni Stallone
January 18, 2022

Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection.

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Nathaniel DeboeverBoris Sepesi
January 18, 2022

Hepatitic Variant of Graft-vs-Host Disease.

American Journal of Clinical Pathology
Tom Z LiangShefali Chopra
January 17, 2022

Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
Mandana NamayandehMazyar Ziyaeyan
January 17, 2022

Factors Affecting Knowledge Levels and Protective Behaviors to Prevent the Development of Skin Cancer in Organ Transplant Recipients as a High-Risk Group.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
Yaprak Sarigöl OrdinTuğçe Yeşilyaprak

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2022 Meta ULC. All rights reserved